Literature DB >> 12759919

The person trade-off method and the transitivity principle: an example from preferences over age weighting.

Paul Dolan1, Aki Tsuchiya.   

Abstract

The person trade-off (PTO) is increasingly being used to elicit preferences in health. This paper explores the measurement properties of the PTO method in the context of a study about how members of the public prioritise between patients of different ages. In particular, it considers whether PTO responses satisfy the transitivity principle; that is, whether one PTO response can be inferred from two other PTO responses. The results suggest that very few responses to PTO questions satisfy cardinal transitivity condition. However, this study has produced results that suggest that cardinal transitivity will hold, on average, when respondents who fail to satisfy the ordinal transitivity condition have been excluded from the analysis. This suggests that future PTO studies should build in checks for ordinal transitivity. Copyright 2002 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2003        PMID: 12759919     DOI: 10.1002/hec.731

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  4 in total

Review 1.  Societal values in the allocation of healthcare resources: is it all about the health gain?

Authors:  Tania Stafinski; Devidas Menon; Deborah Marshall; Timothy Caulfield
Journal:  Patient       Date:  2011       Impact factor: 3.883

2.  Cost-Value Analysis and the SAVE: A Work in Progress, But an Option for Localised Decision Making?

Authors:  Jonathan Karnon; Andrew Partington
Journal:  Pharmacoeconomics       Date:  2015-12       Impact factor: 4.981

3.  When are person tradeoffs valid?

Authors:  Jason N Doctor; John Miyamoto; Han Bleichrodt
Journal:  J Health Econ       Date:  2009-06-25       Impact factor: 3.883

4.  A person trade-off study to estimate age-related weights for health gains in economic evaluation.

Authors:  Stavros Petrou; Ngianga-Bakwin Kandala; Angela Robinson; Rachel Baker
Journal:  Pharmacoeconomics       Date:  2013-10       Impact factor: 4.981

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.